Sean Wirtjes

Chief Financial Officer at RAPID MICRO BIOSYSTEMS

Since September 2018

Age

54 years

Education

Earned a B.S. in Accounting from the Carroll School of Management at Boston College.

Tenure

Joined Rapid Micro Biosystems, Inc. in September 2018 as Chief Financial Officer.

Also at RAPID MICRO BIOSYSTEMS

John Wilson

Chief Operating Officer

About

Sean Wirtjes is the Chief Financial Officer at Rapid Micro Biosystems, Inc., having assumed the role in September 2018. His current responsibilities include overseeing financial management and maintaining compliance with regulatory requirements.

He earned a B.S. in Accounting from the Carroll School of Management at Boston College, which laid the foundation for his successful career in finance. Prior to joining Rapid Micro Biosystems, he gained valuable experience through other leadership roles, including a significant position at Boston Scientific Corporation.

At 54 years old as of April 2024, his professional journey reflects a strong commitment to financial leadership and strategic oversight. His tenure at Rapid Micro Biosystems underscores his expertise in managing complex financial operations and ensuring organizational compliance.

Past Roles

Organization	Role	Date Range	Details
Boston Scientific Corporation	Vice President, Finance and Controller, Asia Pacific, Middle East, and Africa	Aug 2012 - Jul 2016	Led all aspects of financial management for the region

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$432,640	Annual	4% increase from 2022 base salary
401(k) Matching Contributions	$13,966	As per plan annual contributions	Part of the company’s Savings and Investment Plan
Insurance Premiums	$14,607	Annual	Covers medical and life insurance
Stock Awards	$97,464	Granted during 2023	RSUs granted with grant date fair value calculated per FASB ASC Topic 718
Option Awards	$125,118	Granted during 2023	Options granted with full grant-date fair value per FASB ASC Topic 718
Retention Bonus	$62,400	Cash payment on/within 10 days after September 1, 2023 (or within 30 days upon qualifying termination)	Contingent upon continued employment or qualifying termination; not performance-based

Performance Compensation

Data from FY 2023

Non-Equity Incentive Plan Compensation ($177,123) for FY 2023

This cash bonus is determined by the achievement of both corporate and individual performance goals. Below is the detailed breakdown:

Metric	Target/Threshold	Weight (%)	Actual Achievement (%)	Payout (%)	Additional Details
Commercial Execution & Revenue Growth	As defined per plan	50	76	29	Evaluated for FY 2023
New Product Development	100% target	20	100	20	Achieved target exactly
Customer Experience	100% target	10	127	13	Overachievement noted
Gross Margin Improvement	N/A	10	0	0	Target not met
Employee Engagement, Recruitment & Development	100% target	10	200	20	Overachievement noted
Total Corporate Performance	Composite	75*	81 (aggregate)	N/A	Weighted aggregated performance
Individual Performance Goals	N/A	25	84	N/A	Evaluated separately for FY 2023
Target Bonus	50% of Base Salary	N/A	N/A	N/A	Final bonus amount determined as $177,123

*Corporate performance represents 75% of the overall performance evaluation. The bonus is cash-based, with no vesting schedule, grant date, or stock price since it is not share-based.